Skip to content

AN2 Therapeutics, Inc.

ANTX· NasdaqCore metricsCIK 1880438

Pharmaceutical preparations551 peers

Last sale
Nov 6, 2026 · +0.50%
Market cap
$151.40M
37.94M shares
Filings
390
—
—
—
-$7.96M
Q3 2026N/M FY25 yoy
-$8.67M
Q3 2026N/M FY25 yoy
—
—
—
-$0.17
Q3 2026N/M FY25 yoy
$20.21M
Q3 2026−6.6% FY25 yoy
$151.40M
—
—
2.0×
—
—

FY2025 figures · derived

Price

$3.99+250.00%+$2.85past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$24.77MFY 2025
$54.87M0FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$24,769,000reported
FY 20242024-12-31$40,488,000reported
FY 20232023-12-31$54,871,000reported
FY 20222022-12-31$28,511,000reported
FY 20212021-12-31$16,156,000reported

Pharmaceutical preparations

AN2 Therapeutics, Inc. is the 265th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

AN2 Therapeutics, Inc. · CIK 1880438 · Engraved from SEC EDGAR